UCSF Licenses Heart Gene IP from Celera

UCSF will use Celera's KIF6 genetic variant discoveries to develop a test for cardiovascular risk and statin benefit.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.